Multi-drug resistant escherichia coli with extended-spectrum beta-lactamase activity and fluoroquinolone resistance isolated from clinical infections in dogs

Aust Vet J. 2001 Sep;79(9):621-3. doi: 10.1111/j.1751-0813.2001.tb10783.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Dog Diseases / drug therapy*
  • Dog Diseases / microbiology
  • Dogs
  • Drug Resistance, Multiple, Bacterial
  • Drug Synergism
  • Escherichia coli / drug effects*
  • Escherichia coli / enzymology
  • Escherichia coli / growth & development
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / veterinary*
  • Female
  • Fluoroquinolones / pharmacology*
  • Length of Stay
  • Male
  • Microbial Sensitivity Tests / veterinary
  • beta-Lactam Resistance
  • beta-Lactamases / metabolism
  • beta-Lactams

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • beta-Lactams
  • beta-Lactamases